• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-APOL1-Specific

APOL1-Specific Monoclonal Antibody for FC, IF, IHC, IP, WB, ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

WB, IP, IHC, IF, FC, ELISA

Conjugaison

Non conjugué

CloneNo.

1G12D11

N° de cat : 66124-1-Ig

Synonymes

APO L, APOL, APOL I, APOL1, APOL1-Specific, Apolipoprotein L, Apolipoprotein L I, apolipoprotein L, 1, Apolipoprotein L1



Applications testées

Résultats positifs en WBtissu plasmatique humain
Résultats positifs en IPtissu plasmatique humain
Résultats positifs en IHCtissu hépatique humain, tissu rénal humain
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IFcellules HepG2
Résultats positifs en cytométriecellules HepG2

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:20000-1:100000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochimie (IHC)IHC : 1:500-1:5000
Immunofluorescence (IF)IF : 1:50-1:500
Flow Cytometry (FC)FC : 0.20 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

66124-1-Ig cible APOL1-Specific dans les applications de WB, IP, IHC, IF, FC, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéeHumain
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène APOL1-Specific Protéine recombinante Ag2016
Nom complet apolipoprotein L, 1
Masse moléculaire calculée 44 kDa
Poids moléculaire observé 39-45 kDa
Numéro d’acquisition GenBankBC017331
Symbole du gène APOL1
Identification du gène (NCBI) 8542
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Human apolipo-protein L1 (APOL1) is a minor component of plasma high density lipoprotein (HDL) particles, acting as an interacting protein of apolipoprotein A1 (ApoA1). The human ApoL protein family was thought to be predominantly involved in lipid transport and metabolism. APOL1 is also involved in host innate immunity against Trypanosoma parasites. Once activated, APOL1 can lyse the parasite and protect human from infection. Genetic variants in APOL1 gene, which are found in African ancestry with high frequency, associate with chronic kidney disease, like focal segmental glomerulosclerosis (FSGS), HIV-associated nephropathy (HIVAN), and hypertensive nephropathy. APOL1 share structural and functional similarities with proteins of the Bcl-2 family and may has roles in apoptosis and autophagy. It is notable that APOL1 exists only in human and a few other primate species, and mouse does not express an APOL1 orthologue. This antibody recognizes the endogenous ApoL1 of 39-45 kDa in blood lysate. This antibody is specific to APOL1.

Protocole

Product Specific Protocols
WB protocol for APOL1-Specific antibody 66124-1-IgDownload protocol
IHC protocol for APOL1-Specific antibody 66124-1-IgDownload protocol
IF protocol for APOL1-Specific antibody 66124-1-IgDownload protocol
IP protocol for APOL1-Specific antibody 66124-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
WB,IF

Immunity

APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis.

Authors - Junnan Wu
WB

J Clin Invest

The key role of NLRP3 and STING in APOL1-associated podocytopathy.

Authors - Junnan Wu
humanWB

J Am Soc Nephrol

Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function.

Authors - Somenath Datta
WB

Mol Ther

Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.

Authors - Ya-Wen Yang
humanWB,IF

Elife

Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity.

Authors - Joseph A Giovinazzo
humanWB,IHC

Neurobiol Dis

Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.

Authors - Yanaika S Hok-A-Hin

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Jonathan (Verified Customer) (11-11-2019)

Works well for WB.

  • Applications: Western Blot,